Advertisement

Topics

Latest Biotechnology, Pharmaceutical and Healthcare News from Brad Loncar

18:43 EST 21st February 2019 | BioPortfolio

Here are the most relevant search results for "Brad Loncar" found in our extensive news archives from over 250 global news sources.

More Information about Brad Loncar on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Brad Loncar for you to read. Along with our medical data and news we also list Brad Loncar Clinical Trials, which are updated daily. BioPortfolio also has a large database of Brad Loncar Companies for you to search.

Showing News Articles 1–25 of 792 from Brad Loncar

Thursday 21st February 2019

Mirati stock price has been nothing short of amazing. $4.35 a year and a half ago when these options were granted. That’s got to be the best biotech stock over that time, right? https://www.sec.gov/Archives/edgar/data/1576263/000162828019001605/form8-k

Mirati stock price has been nothing short of amazing. $4.35 a year and a half ago when these options were granted. That’s got to be the best biotech stock over that time, right? https://www.sec.gov/Archives/edgar/data/1576263/000162828019001605/form8-kxfebruary2019xfahee.htm …

Big scoop. The Sackler deposition. https://twitter.com/statnews/status/1098655229741010946 …

Big scoop. The Sackler deposition. https://twitter.com/statnews/status/1098655229741010946 …

God bless Florida & America. pic.twitter.com/GX5zeXsJWd

God bless Florida & America. pic.twitter.com/GX5zeXsJWd

I get that this is news, but classic example of how blown out of proportion Tesla stock moves are talked about. Sharply drop? This is like a $30 stock going down 45 cents. You’d think it got cut in half. https://twitter.com/cnbcnow/status/10986387313246

I get that this is news, but classic example of how blown out of proportion Tesla stock moves are talked about. Sharply drop? This is like a $30 stock going down 45 cents. You’d think it got cut in half. https://twitter.com/cnbcnow/status/1098638731324678144 …

There are a lot of companies in biotech that have been left on the side of the road lately like Immune Design. Many for good reason, but there are some hidden gems around.

There are a lot of companies in biotech that have been left on the side of the road lately like Immune Design. Many for good reason, but there are some hidden gems around.

Looking back on it, that was one year ago (March 6) when I was in town for @ldtimmerman’s pre-Everest event at the Hutch. Feels more like 3-4 years.

Looking back on it, that was one year ago (March 6) when I was in town for @ldtimmerman’s pre-Everest event at the Hutch. Feels more like 3-4 years.

The fighter, the saint, and the odd man out: the seven executives who will defend pharma before Congress https://www.statnews.com/2019/02/21/executives-defend-pharma-before-congress/ … via @damiangarde and @NicholasFlorko

The fighter, the saint, and the odd man out: the seven executives who will defend pharma before Congress https://www.statnews.com/2019/02/21/executives-defend-pharma-before-congress/ … via @damiangarde and @NicholasFlorko

Last time I was in Seattle, I sat down with Carlos at their offices. Was very impressed by what a dedicated scientist he was. Happy to see this positive exit after what has been a rocky road. http://ir.immunedesign.com/news-releases/news-release-details/m

Last time I was in Seattle, I sat down with Carlos at their offices. Was very impressed by what a dedicated scientist he was. Happy to see this positive exit after what has been a rocky road. http://ir.immunedesign.com/news-releases/news-release-details/merck-acquire-immune-design …

Wednesday 20th February 2019

Very happy for @Perth_Tolle. Incredible person who has worked so hard for this day. Good luck! https://twitter.com/ericbalchunas/status/1098363068642443266 …

Very happy for @Perth_Tolle. Incredible person who has worked so hard for this day. Good luck! https://twitter.com/ericbalchunas/status/1098363068642443266 …

Our @Aiims1742 shares insights on the current treatment landscape of #pancreaticcancer and what's ahead with clinical trials: http://bit.ly/2NnCT0R  @cure_magazine #pancsm #endcancer

Our @Aiims1742 shares insights on the current treatment landscape of #pancreaticcancer and what's ahead with clinical trials: http://bit.ly/2NnCT0R  @cure_magazine #pancsm #endcancer

The Adam Singer era at Invitae is off to a good start.

The Adam Singer era at Invitae is off to a good start.

pic.twitter.com/uoLis59CDB

pic.twitter.com/uoLis59CDB

pic.twitter.com/PQdYmsPUzx

pic.twitter.com/PQdYmsPUzx

Hanging with the Baltimore Orioles this morning.pic.twitter.com/gFpdH6hmJd

Hanging with the Baltimore Orioles this morning. pic.twitter.com/gFpdH6hmJd

Nice job from a social media standpoint on the video commentary to go along with the news. Think we will see a lot more of this in the future. https://twitter.com/moderna_tx/status/1098206401300758528 …

Nice job from a social media standpoint on the video commentary to go along with the news. Think we will see a lot more of this in the future. https://twitter.com/moderna_tx/status/1098206401300758528 …

Derek DiRocco, the investor quoted here, was a very early days participant on biotwitter. Great to see those who have moved on to do good things in their careers. https://www.businesswire.com/news/home/20190220005028/en/Peloton-Therapeutics-Secures-150-Mi

Derek DiRocco, the investor quoted here, was a very early days participant on biotwitter. Great to see those who have moved on to do good things in their careers. https://www.businesswire.com/news/home/20190220005028/en/Peloton-Therapeutics-Secures-150-Million-Series-Financing …

One of my predictions for 2019 is that bispecifics will be hot. Not off to a great start after another hold for a CD3. These can be important therapies. We had the CRS rollercoaster in the early days of CART. Hoping antibody companies are able to get a ha

One of my predictions for 2019 is that bispecifics will be hot. Not off to a great start after another hold for a CD3. These can be important therapies. We had the CRS rollercoaster in the early days of CART. Hoping antibody companies are able to get a handle on it the same.

CStone prices Hong Kong IPO at HK$12/share, ~ midpoint of the range. Deal size $285m. Implied mkt cap $1.5bn. Will list on 26 Feb.

CStone prices Hong Kong IPO at HK$12/share, ~ midpoint of the range. Deal size $285m. Implied mkt cap $1.5bn. Will list on 26 Feb.

Tuesday 19th February 2019

Valeant Pharmaceuticals hired McKinsey to help advise it on raising prices for vital medicines. But the relationship went deeper: Through its secretive $12.3 billion hedge fund, McKinsey was also a Valeant shareholder. https://nyti.ms/2DXLXVA 

Valeant Pharmaceuticals hired McKinsey to help advise it on raising prices for vital medicines. But the relationship went deeper: Through its secretive $12.3 billion hedge fund, McKinsey was also a Valeant shareholder. https://nyti.ms/2DXLXVA 

Gr8 news for patients and @InterceptPharma! Also, as first positive P3 study in NASH, this will facilitate wave of new Rx! https://www.statnews.com/2019/02/19/with-nash-results-intercept-pharma-will-seek-approval-for-first-ever-treatment-for-fatty-liver-c

Gr8 news for patients and @InterceptPharma! Also, as first positive P3 study in NASH, this will facilitate wave of new Rx! https://www.statnews.com/2019/02/19/with-nash-results-intercept-pharma-will-seek-approval-for-first-ever-treatment-for-fatty-liver-condition/ …

Twitter is doing its thing this morning expecting perfect data...not going to happen in NASH. To hit a fibrosis endpoint is a meaningful thing. Clear win even with the AE baggage.

Twitter is doing its thing this morning expecting perfect data...not going to happen in NASH. To hit a fibrosis endpoint is a meaningful thing. Clear win even with the AE baggage.

Walmart and a NASH drug up on the same day.....

Walmart and a NASH drug up on the same day.....

Monday 18th February 2019

As medical costs mount, Japan to weigh cost-effectiveness in setting drug prices https://reut.rs/2GOpHAB 

As medical costs mount, Japan to weigh cost-effectiveness in setting drug prices https://reut.rs/2GOpHAB 

Random advertisement I came across while surfing NYT's home page. #immunotherapy $BMYpic.twitter.com/lZSRel3h67

Random advertisement I came across while surfing NYT's home page. #immunotherapy $BMY pic.twitter.com/lZSRel3h67

Took these photos a couple of years back at the Eisenhower library and museum in Abilene, Kansas. #PresidentsDay pic.twitter.com/IsbdRt0hXt

Took these photos a couple of years back at the Eisenhower library and museum in Abilene, Kansas. #PresidentsDay pic.twitter.com/IsbdRt0hXt


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks